Shanghai, China

Mingsong Wei


 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovative Contributions of Mingsong Wei in the Field of EGFR Inhibitors

Introduction

Mingsong Wei, an accomplished inventor based in Shanghai, China, has made significant contributions to the field of cancer treatment through his innovative work on epidermal growth factor receptor (EGFR) inhibitors. With a total of two patents to his name, Wei is recognized for his advancements in the preparation methods and applications of these crucial compounds.

Latest Patents

Mingsong Wei's latest patents focus on 4-substituted-2-(N-(5-substituted allyl amide)phenyl)amino)pyrimidine derivatives, which serve as EGFR inhibitors. These derivatives have shown promise in inhibiting various EGFR mutants, including L858R and T790M, as well as the exon 19 deletion activating mutant. The potential applications of these compounds are particularly significant in the treatment and prevention of non-small cell lung cancer, addressing diseases that are mediated by EGFR mutant activity.

Career Highlights

Throughout his career, Mingsong Wei has been associated with prominent companies in the pharmaceutical sector. Notably, he has worked at Shanghai Hansoh Biomedical Co., Ltd. and Jiangsu Hansoh Pharmaceutical Group Co., Ltd. His work in these organizations has contributed to the development of groundbreaking treatments in oncology, particularly focusing on targeting EGFR-related pathways.

Collaborations

In his professional journey, Mingsong Wei has collaborated with esteemed colleagues such as Guangjun Sun and Songliang Tan. These partnerships have fostered an environment of innovation and have propelled forward the research and development of new therapeutic strategies to combat cancer.

Conclusion

Mingsong Wei stands out as a vital contributor to cancer pharmacology, particularly through his work on EGFR inhibitors. With a firm grounding in both practical applications and research, his patents represent a step forward in developing more effective therapies for patients battling cancer, highlighting the importance of innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…